Search results for

In a wide-ranging interview with NPR's Michel Martin, Rep. Adam Schiff discusses his regrets from President Donald Trump's first impeachment trial and his relationship with his GOP colleagues.

Craig has been a terrific James Bond, maybe even the best. But there's something a little too strained about the tragic emotional arc his character has carried with over the past several movies.

A new coronavirus variant — known as delta plus — has cropped up in the U.K. There's concern it could be more dangerous than the highly contagious delta variant. What does the science actually show?

NPR's Sarah McCammon talks with Elisa Gould, a senior economist at the Economic Policy Institute, about the latest monthly jobs report published Friday.

Severe thunderstorms and winds up to 70 mph have caused massive power outages across Kansas and shut down the Kansas City International Airport.

Families of victims of the Sandy Hook Elementary massacre hope the $73 million settlement will put companies that insure gun-makers on notice that they could be on the hook for huge future payouts.

Lionel Tate is back in jail for allegedly holding up a pizza deliveryman. The 18-year-old Florida youth was the youngest person to be sent to prison for life in U.S. history. At age 12, he was accused of murdering his 6-year-old neighbor and friend Tiffany Eunick when he claimed he was demonstrating wrestling moves. Ed Gordon talks with Sgt. DeLacy Davis, a mentor and one of several supporters that put together a "re-entry into society plan" for Tate.

By a 6-to-3 vote the U.S. Supreme Court has upheld an Oregon law that allows doctors to prescribe lethal doses of narcotics to terminally ill patients who want to end their lives. The physician-assisted suicide law is the only one in the country.

The White House has requested $22.5 billion in additional COVID relief, but 35 GOP senators warned they won't support more until Biden provides an accounting of trillions in prior relief spending.

NPR has learned that Pfizer and BioNtech have gathered additional data that the companies say strengthen their case for authorizing the COVID-19 vaccine for children younger than age five.